MAPT and Alzheimer disease: Recent RNA expression chip datasets have confirmed downregulated SIRT3 mRNA levels compared to controls in post-mortem AD brains and in 3xTG AD mice expressing microtubule associated protein tau (MAPT), amyloid-beta precursor protein (APP), and presenilin-1(PSEN1) transgenes [15].